Over recent years our understanding of the functions of the heparan sulphate (HS) family of complex polysaccharides has shifted dramatically. Once seen as simply structural scaffolding in the extracellular matrix, they are now viewed as critical players in the regulatory network of cells. They are strategically located at the cell surface and in the extracellular matrix, and there has been an increasing realization that specific sequences in the H S chains are designed for selective interactions with many proteins. Functionally, these interactions result in regulation of the protein activities. It is becoming clear that H S functions as a new class of multifunctional cell regulator. There is also growing evidence that cells can dynamically alter the structure of H S sequences that they express. Here we review recent developments and describe evidence for regulated changes in the synthesis and structure of HS chains expressed during early mouse brain development. The data suggest a new concept in which dynamic changes in biosynthesis of different H S sequences create distinct cellular H S repertoires, the heparanome [ 11. Their expression, in specific spatio-temporal patterns, is likely to endow organisms with novel regulatory mechanisms for controlling the activity of specific HS-binding proteins.
Introduction
Heparan sulphate (HS) is a member of the glycosaminoglycan family of macromolecules which also includes chondroitin sulphate, dermatan sulphate and keratan sulphate. These molecules are linear polysaccharides made up of repeating disaccharide unit backbones on to which are superimposed specific modification patterns, most notably addition of sulphate groups. HS is the family member with the most highly variable structure, due to the highly sulphated and polymorphic nature of the sequences expressed within its chains. These sulphated structural motifs are primarily responsible for the many protein-binding and regulatory properties of H S [2] . H S chains are normally attached to core proteins in the form of H S proteoglycans (HSPGs), which are strategically located at the cell surface and in the extracellular matrix. Recent striking evidence of in vivo regulatory roles for H S has come from genetic studies in Drosophila, Caenorhabditis elegans and mice. Mutations or loss of function of H S biosynthetic enzymes or HSPG core proteins have been shown to dramatically perturb various aspects of development, and indicate that H S has functional roles in cell-cell signalling and morphogenesis (for detailed reviews see [3-61). Many recent developments in this field have heightened the future prospects for understanding the mechanisms of functional specificity of these enigmatic molecules [ 11.
HS: a multifunctional cell regulator
H S interacts with a wide variety of proteins including growth factors, enzymes, extracellular matrix proteins and proteins found on the surfaces of pathogens. There is a strong body of evidence that specific interactions between distinct structural motifs in H S and many HS-binding proteins provide the molecular basis for the functions of H S [7,8]. In many examples of HS-protein pairings there is now substantial evidence that the interactions are highly specific and serve regulatory roles [2]. In essence the main role of H S is to act as a 'catalyst of molecular encounters' [9]. T h e mechanisms of action of H S are an active area of investigation which has revealed a number of distinct modes of action [l]. T h e key models are the action of HS in mediating the protein-protein interactions required for the anticoagulant activity of antithrombin I11 and signalling by the fibroblast growth factor (FGF) family. H S also functions to restrict proteins to specific locations ; this is probably important for restricting protein functions to specific cellular domains, for example during development or wound healing.
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A major function of H S is as a co-receptor for extracellular ligands such as soluble growth factors, as demonstrated by the F G F family, where HS modulates the interaction of F G F with its receptor tyrosine kinase. H S activates signalling in this case by participating in the formation of a ternary complex, mediated by specific interactions of the HS with both the growth factor and its receptor. H S is not only required for FGFs to bind and signal through FGF receptors (FGFRs), but the presence or absence of specific sulphate groups within HS can dictate which members of the FGF family can signal through which receptors [ lo].
H S structure and biosynthesis
The biosynthesis of H S involves a complex set of Golgi enzyme reactions that initially produce a non-sulphated polysaccharide chain precursor. This is followed by the superimposition of a sequential series of modifications, in particular, complex patterns of sulphate group addition at selective positions. Importantly, the system is not template-driven and these reactions do not go to completion. This produces a high degree of structural diversity of HS sugar sequences. It also imparts an ordered structure to H S chains in which domains with differing types and density of modifications are spaced apart along the molecule [ l l ] (see Figure 1) . Regions where the precursor polysaccharide has undergone relatively few modifications consist mainly of GlcA-GlcNAc repeats and are called N-acetylated domains. These act as spacers between the highly modified, sulphated domains (S-domains). In these domains (usually 3-8 disaccharide units in length) extensive modifications occur, especially sulphate group additions and epimerization of glucuronic acid (GlcA) to iduronic acid. The latter modification is critical since the flexibility of this monosaccharide allows it to adopt different conformations and influence the spatial distribution of sulphate, carboxy and hydroxy groups. Domains which flank the S-domains that have alternating Nacetylated and N-sulphated disaccharides have also been observed [ 121. Average chain length is typically 50-200 disaccharide units (25-100 kDa).
Chains adopt an extended helical coil in solution, with a disaccharide unit length of approximately 0.75 nm, which makes them a dominant feature of cell surfaces.
H S chain modifications vary greatly and this leads to the many binding and regulatory properties of HS towards proteins. The potential variations in even short saccharide sequences are enormous and H S is one of the most informationdense molecules in biology [13] . A number of features have been revealed by studies on variations in HS structure. The model is based on data from structural studies on HS extracted from embryonic day I0 (E 10) and day I 2 (E 12) neuroepithelial cells in primary culture [32] . The predominant alterations are increases in the size, number of sulphated domains and sulphation complexity (in particularthe patterns of 6-0-sulphation) ofthe HS in the E I 2 cells. The rectangular black blocks represent the sulphated domains, the black ovals denote 6-0-sulphate groups and the solid lines between the blocks are unmodified N-acetylated regions. Attered HS structures may be produced by neuroepithelial cells t o regulate their responses t o changing expression patterns of extracellular FGFs.
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H S in the developing mouse neuroepithelium
Mice are proving a particularly useful model for investigation of the dynamic expression of HS and its functional ramifications. The mouse central nervous system develops from the neuroepithelium of the neural tube. Several members of the F G F family, including FGF-1, -2, -8, - 15 and -17, are involved in the formation of differentiated neurons and glia from the neuroepithelium and are expressed in a spatially and temporally specific manner during development [30] . Expression of different members of the FGFR family [3 13 as well as core proteins of different HSPGs is also regulated (M. Ford-Perriss et al., unpublished work). This raises the intriguing possibility that HS functions as a regulator of FGFs in this developing tissue, and prompts the question of whether synthesis of different sulphated sequences in H S is a regulated process in vivo.
Our previous in vitro studies on primary cultures of neuroepithelial cells derived from embryonic day 10 (E10) and 12 (E12) mouse brain showed that specific changes in H S structure occur at this developmental stage, when neurons are being generated. These changes include altered patterns of 6-O-sulphation, increased chain length and increased number of sulphated domains [32] (see Figure 1) . These changes could be important in regulating the switch to neuronal differentiation at this crucial stage of development when an increasing proportion of the population of proliferating neural precursor cells is committing to the neuronal lineage [33] . Importantly, the structural changes in HS result in a functional effect in terms of an increase in high-affinity binding to FGF-1 at E l 2 [32] . It is possible that regulated changes in HS structure form part of the network of regulatory systems which control neurogenesis. Interestingly, the different E l 0 and E l 2 H S species also have distinct abilities to affect axon targeting when added exogenously in a Xenopus optic nerve model [34] .
Expression of H S sulphotransferases in developing mouse neuroepithelium
The in vitro evidence for altered HS structures at different stages in the developing mouse brain raises the question of whether changes in the expression of HS sulphotransferase enzyme isoforms occur. Could they be in part responsible for generating specific changes in HS structure ? As a first step in addressing this point, we have begun investigating the expression of mRNA transcripts for the different isoforms of HS sulphotransferase enzymes in primary neuroepithelial cells in culture. Using reverse transcriptase PCR we have found significant differences between the mRNA expression profiles at E l 0 and E l 2. The one known isoform of 2 0 S T was expressed at both E l 0 and E l 2, whereas the 6 0 S T and N D S T isoforms were differentially expressed (Figure 2 ). 6 0 S T 1 and 6 0 S T 2 were expressed at both stages, in contrast to 60ST3, which was absent at E10, but expressed at E12. N D S T l was expressed only at E l 2 whereas NDST2 was expressed only at E10. Since sulphotransferase isoforms have different substrate specificities and thus the potential to produce different saccharide sequences [21, 24] , these changes probably contribute to the altered structures of HS produced by these cells. For example, the additional expression of 6 0 S T 3 at El2 may account for altered patterns of 6-0-sulphation in the E l 2 HS [32] . In addition, although the average level of N-sulphation of H S chains is similar at E l 0 and E12, the reversed expression of N D S T l
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and 2 could well contribute to subtle alterations in the distribution of N-sulphate groups observed in structural studies [32] . . The cells were solubilized in Trizol (Gibco Life Technologies) and RNA was extracted from the aqueous phase using isopropanol as per the manufacturer's instructions. The presence of mRNA transcripts was assessed by reverse transcriptase PCR Reverse transcription to generate cDNAs was performed on I p g of purified RNA with avian myeloblastosis virus reverse transcriptase (Promega) for I h at 42 "C followed by 30 cycles of PCR with Taq polymerase (Promega). Forward and reverse primers were designed using the published sequences of murine 2OST [26] , and NDST I and 2 [36] . PCR products were separated on I .2% agarose gels containing ethidium bromide.
Correlation of the in vitro sulphotransferase expression profiles with the actual in vivo situation, and with protein-expression levels, remains to be examined. Nevertheless, our data from primary cells strongly indicate that the different 6 0 S T and N D S T isoforms are differentially expressed over short time spans during the proliferation and differentiation of the neuroepithelium. This suggests that the expression of these enzymes is dynamically regulated, and contributes to production of altered HS structures. An important question is whether these HS species have altered functional properties. Previous studies showed that the E l 2 HS had an increased affinity for Embryonic day I0 (E 10) and day I 2 (E 12) mouse neuroepithelial cells were obtained by dissection and maintained in primary cutture and HSPGs were extracted and purified as described previously [32] . The ability of these HSPG samples t o activate FGF-2 signalling was assessed based on stimulation of proliferation ofthe BaF3 FRI cell line expressing FGFRI (Ilk splice variant) as described previously using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide ( M V colorimetric assay of cell number [ 101. Since these cells lack endogenous HS they are dependent on exogenous addition of competent HS. 
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